Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s traded shares stood at 0.79 million during the last session, with the company’s beta value hitting 0.65. At the close of trading, the stock’s price was $0.67, to imply a decrease of -3.80% or -$0.03 in intraday trading. The TLSA share’s 52-week high remains $1.74, putting it -159.7% down since that peak but still an impressive 38.81% since price per share fell to its 52-week low of $0.41. The company has a valuation of $74.47M, with an average of 0.48 million shares in intraday trading volume over the past 10 days and average of 305.99K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Tiziana Life Sciences Ltd (TLSA), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give TLSA a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information
After registering a -3.80% downside in the last session, Tiziana Life Sciences Ltd (TLSA) has traded red over the past five days. The 5-day price performance for the stock is -19.11%, and -28.78% over 30 days. With these gigs, the year-to-date price performance is 20.18%. Short interest in Tiziana Life Sciences Ltd (NASDAQ:TLSA) saw shorts transact 0.21 million shares and set a 0.57 days time to cover.
TLSA Dividends
Tiziana Life Sciences Ltd has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Fidelity NASDAQ Composite Index ETF and Fidelity NASDAQ Composite Index Fund as the top two Mutual Funds with the largest holdings of the Tiziana Life Sciences Ltd (TLSA) shares. Going by data provided on Oct 31, 2024 , Fidelity NASDAQ Composite Index ETF holds roughly 162.8 shares. This is just over 0.15% of the total shares, with a market valuation of $0.11 million. Data from the same date shows that the other fund manager holds a little less at 55.88, or 0.05% of the shares, all valued at about 37609.0.
